Q32 Bio (QTTB) Net Income Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 60.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 19.97% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | -4.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.14% |
| Dec 31, 2025 | 54.25% |
| Sep 30, 2025 | 38.42% |
| Jun 30, 2025 | 30.23% |
| Mar 31, 2025 | -28.44% |
| Dec 31, 2024 | 24.96% |
| Sep 30, 2024 | 16.85% |
| Jun 30, 2024 | 20.15% |
| Mar 31, 2024 | 46.17% |
| Dec 31, 2023 | 3.07% |
| Sep 30, 2023 | 20.91% |
| Jun 30, 2023 | 45.23% |
| Mar 31, 2023 | 42.16% |
| Dec 31, 2022 | -12.67% |
| Sep 30, 2022 | -2.21% |
| Jun 30, 2022 | -2.07% |
| Mar 31, 2022 | 80.54% |
| Dec 31, 2021 | -21.37% |
| Sep 30, 2021 | -29.33% |
| Jun 30, 2021 | -34.89% |
| Mar 31, 2021 | 52.82% |
| Dec 31, 2020 | -35.76% |
| Sep 30, 2020 | -62.93% |
| Jun 30, 2020 | -80.57% |
| Mar 31, 2020 | -96.19% |